• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    7.39 Down 0.37(4.77%) Aug 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.76
    Open:7.74
    Bid:N/A
    Ask:9.74 x 300
    1y Target Est:14.86
    Beta:2.03761
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:7.37 - 7.87
    52wk Range:6.71 - 16.87
    Volume:2,005,422
    Avg Vol (3m):2,609,360
    Market Cap:1.01B
    P/E (ttm):N/A
    EPS (ttm):-0.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACHNDown 4.77%1.01B
    GSKDown 0.78%98.93B
    JNJDown 1.25%260.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,488.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.36
    Quarterly EPS Est (Sep-15) :0.01
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-1.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback